Patents by Inventor Eric Levy
Eric Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12516334Abstract: The invention provides three novel disarmed strains of Agrobacterium tumefaciens bacteria useful for the transformation of plants. The invention provides three engineered A. tumefaciens Chry5 strains or bacterial cells thereof which comprise the Chry5 strain chromosomal background and a disarmed pTiChry5 vector, and methods of using said bacterial strains or cells for transformation of fungal or plant cells, in particular dicot or monocot plant cells, including soybean, maize, wheat, and sugarcane cells. The invention further relates to the transgenic plants created by these methods.Type: GrantFiled: October 18, 2022Date of Patent: January 6, 2026Assignee: Syngenta Crop Protection AGInventors: Zhongying Chen, Qiudeng Que, Mark Scott Rose, Heng Zhong, Mary-Dell Chilton, Eric Levy, Yingping Lucy Qin
-
Publication number: 20240185952Abstract: A method of detecting loss of heterozygosity in HLA alleles is provided. The method can include accessing a trained machine-learning model, which was trained using a training data set that included at least a training data set that includes an adjusted B allele frequency that represents a ratio between a first B allele frequency of heterozygous alleles in the tumor sample that correspond to the genomic region and a second B allele frequency of heterozygous alleles in the genomic region and associated with one or more control samples. The method can also include using the machine-learning model to generate a result corresponding to a probability of whether a loss of heterozygosity exists in an HLA allele identified in the biological sample of the particular subject by processing the sequence data using the machine-learning model.Type: ApplicationFiled: April 21, 2022Publication date: June 6, 2024Inventors: Rachel Marty PYKE, Dattatreya MELLACHERUVU, Steven DEA, Charles Wilbur ABBOTT, Simo V. ZHANG, Eric LEVY, John WEST, Richard CHEN, Sean Michael BOYLE
-
Publication number: 20230130592Abstract: The invention provides three novel disarmed strains of Agrobacteriumtumefaciens bacteria useful for the transformation of plants. The invention provides three engineered A. tumefaciens Chry5 strains or bacterial cells thereof which comprise the Chry5 strain chromosomal background and a disarmed pTiChry5 vector, and methods of using said bacterial strains or cells for transformation of fungal or plant cells, in particular dicot or monocot plant cells, including soybean, maize, wheat, and sugarcane cells. The invention further relates to the transgenic plants created by these methods.Type: ApplicationFiled: October 18, 2022Publication date: April 27, 2023Applicant: SYNGENTA PARTICIPATIONS AGInventors: Zhongying Chen, Qiudeng Que, Mark Scott Rose, Heng Zhong, Mary-Dell Chilton, Eric Levy, Yingping Lucy Qin
-
Publication number: 20230115039Abstract: The disclosure provides methods for predicting surface-presenting peptides using binding and surface-presentation characteristics. The method can include accessing a trained machine-learning model that is configured to generate an output that indicates an extent to which the one or more expression levels and the one or more peptide-presentation metrics are related in accordance with a population-level relationship between expression and presentation. For each peptide of the set of peptides for a tissue sample, a score can be determined using the machine-learning model and genomic and transcriptomic data corresponding to the peptide. The score is predictive of whether a corresponding peptide is a surface-presenting peptide that binds to an MHC molecule and is presented on a cell surface.Type: ApplicationFiled: December 13, 2022Publication date: April 13, 2023Applicant: Personalis, Inc.Inventors: Charles Wilbur ABBOTT, III, Sean Michael BOYLE, Rachel Marty PYKE, Eric LEVY, Dattatreya MELLACHERUVU, Rena MCCLORY, Richard CHEN, Robert POWER, Gabor BARTHA, Jason HARRIS, Pamela MILANI, Prateek TANDON, Paul MCNITT, Massimo MORRA, Sejal DESAI, Juan-Sebastian SALVIDAR, Michael CLARK, Christian HAUDENSCHILD, John WEST, Nick PHILLIPS, Simo V. ZHANG
-
Publication number: 20230050395Abstract: Methods for generating a composite biomarker that identifies a predicted level of responsiveness of a subject to a particular type of an immunotherapy treatment is provided. The method can include generating genomic metrics that represent one or more characteristics corresponding to one or more DNA sequences. The method can also include generating transcriptomic metrics represent one or more characteristics corresponding to a set of peptides that are translated from a corresponding RNA sequence of the one or more RNA sequences. The method can also include generating a composite biomarker score derived from the set of genomic metrics and the set of transcriptomic metrics. The method can also include determining, based on the composite biomarker score, a predicted level of responsiveness of the subject to a particular type of an immunotherapy treatment.Type: ApplicationFiled: October 13, 2022Publication date: February 16, 2023Applicant: Personalis, Inc.Inventors: Charles Wilbur ABBOTT, III, Sean Michael BOYLE, Rachel Marty PYKE, Eric LEVY, Dattatreya MELLACHERUVU, Rena MCCLORY, Richard CHEN, Robert POWER, Gabor BARTHA, Jason HARRIS, Pamela MILANI, Prateek TANDON, Paul MCNITT, Massimo MORRA, Sejal DESAI, Juan-Sebastian SALVIDAR, Michael CLARK, Christian HAUDENSCHILD, John WEST, Nick PHILLIPS, Simo V. ZHANG
-
Patent number: 11505801Abstract: The invention provides three novel disarmed strains of Agrobacterium tumefaciens bacteria useful for the transformation of plants. The invention provides three engineered A. tumefaciens Chry5 strains or bacterial cells thereof which comprise the Chry5 strain chromosomal background and a disarmed pTiChry5 vector, and methods of using said bacterial strains or cells for transformation of fungal or plant cells, in particular dicot or monocot plant cells, including soybean, maize, wheat, and sugarcane cells. The invention further relates to the transgenic plants created by these methods.Type: GrantFiled: July 26, 2018Date of Patent: November 22, 2022Assignee: Syngenta Participations AGInventors: Zhongying Chen, Qiudeng Que, Mark Scott Rose, Heng Zhong, Mary-Dell Chilton, Eric Levy, Yingping Lucy Qin
-
Publication number: 20200208162Abstract: The invention provides three novel disarmed strains of Agrobacterium tumefaciens bacteria useful for the transformation of plants. The invention provides three engineered A. tumefaciens Chry5 strains or bacterial cells thereof which comprise the Chry5 strain chromosomal background and a disarmed pTiChry5 vector, and methods of using said bacterial strains or cells for transformation of fungal or plant cells, in particular dicot or monocot plant cells, including soybean, maize, wheat, and sugarcane cells. The invention further relates to the transgenic plants created by these methods.Type: ApplicationFiled: July 26, 2018Publication date: July 2, 2020Applicant: SYNGENTA PARTICIPATIONS AGInventors: Zhongying Chen, Qiudeng Que, Mark Scott Rose, Heng Zhong, Mary-Dell Chilton, Eric Levy, Yingping Lucy Qin
-
Publication number: 20160235614Abstract: The embodiments shown provide an integrated cryotherapy apparatus to alleviate minor pain while preventing skin and soft tissue damage to the affected area of the body. The apparatus includes a flexible outer sleeve configured to releasably house a portion of the containing element and releasably secure the apparatus to the user's body while ensuring uniform compression and application. Further, an integrated cap includes a liquid crystal display and countdown timer to ensure the prevention of soft tissue damage from excessive icing/cooling.Type: ApplicationFiled: March 3, 2016Publication date: August 18, 2016Inventors: Neil Kay, Eric Levy